News for NLS Pharmaceutics AG (NLSPW)

PR NewswireZURICH, March 10, 2025 ZURICH, March 10, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical co

PR NewswireZÜRICH, Switzerland, Feb. 27, 2025 ZÜRICH, Switzerland, Feb. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) (Nasdaq: NLSPW) ("

PR NewswireZURICH and NESS ZIONA, Israel, Feb. 25, 2025 Companies Advance Collaborative Clinical Development of iTOL-102: A Potential Cure for Diabetes Wit

Pennsylvania-based Lipella Pharmaceuticals Inc. (LIPO) is up over 62 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Shares of Lattice Semiconductor Corporation LSCC rose sharply in pre-market trading after the company reported its fourth-quarter financial results after Monday...

PR NewswireZURICH and NESS ZIONA, Israel, Feb. 10, 2025 Revolutionizing Diabetes Treatment: Introduction of cutting-edge, multi-targeted innovation to tran

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded down 0.04% to 44,865.23 while...

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 150 points on Friday. Following the market opening Friday, the Dow traded u...

PR NewswireZURICH and NESS ZIONA, Israel, Jan. 16, 2025 Kadimastem Approaches Final Steps for Securing Merger CompletionZURICH and NESS ZIONA, Israel, Jan.

U.K.-based Aptorum Group Limited (APM) is up over 329 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

PR NewswireZURICH and NESS ZIONA, Israel, Dec. 30, 2024 The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates

NLS Pharmaceutics and Kadimastem eye January merger

ZURICH, SWITZERLAND / ACCESSWIRE / December 11, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage bioph

PR NewswireZURICH, Dec. 4, 2024 ZURICH, Dec. 4, 2024 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) (Nasdaq: NLSPW) ("NLS" or the "Company"), a Swis

North Carolina-based Cheetah Net Supply Chain Service Inc. (CTNT) is up over 267 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

ZÜRICH, SWITZERLAND / ACCESSWIRE / December 3, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) (NLS), a biopharmaceutical company, is pleased to shar

NLS Pharmaceutics reveals promising preclinical data

ZÜRICH, SWITZERLAND / ACCESSWIRE / November 18, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biop

Shares of Yum China Holdings Inc YUMC rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter EPS and revenues....